Auwera VR, Limame R, Van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ: Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 2010, 103: 532-541. 10.1038/sj.bjc.6605787
Article
Google Scholar
Bekhouche I, Finetti P, Adelaı¨de J, Ferrari A, Tarpin C, Charafe-Jauffret E, Charpin C, Houvenaeghe G, Jacquemier J, Bidaut G, Birnbaum D, Viens P, Chaffanet M, Bertucci F: High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes. PLoS ONE 2011, 6(2):e16950. 10.1371/journal.pone.0016950
Article
Google Scholar
Belkacémi Y, Boussen H, Hamdi-Cherif M, Benider A, Erivan H, Marti H, Boozed K, Bensalem A, Fettouki S, Ben Abdallah M, Abid I, Gligorov J: Young women breast cancer epidemiology in North Africa. 32es Journées de la SFSPM, Strasbourg; 2010:56-67.
Google Scholar
Ben Hamida A, Labidi I, Mrad K, Charafe-Jauffret E, Ben Arab S, Esterni B, Xerri L, Viens P, Bertucci F, Birnbaum D, Jacquemier J: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin. BMC Cancer 2008, 8: 28. 10.1186/1471-2407-8-28
Article
Google Scholar
Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B, Camerlo J, Tagett R, Tarpin C, Houvenaeghel G, Nguyen C, Maraninchi D, Jacquemier J, Houlgatte R, Birnbaum D, Viens P: Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 2004, 64(23):8558-8565. 10.1158/0008-5472.CAN-04-2696
Article
Google Scholar
Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C, Nguyen C, Xerri L, Houlgatte R, Jacquemier J, Viens P, Birnbaum D: Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005, 65(6):2170-2178. 10.1158/0008-5472.CAN-04-4115
Article
Google Scholar
Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavare S, Caldas C, Miska EA: MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007, 8: R214. 10.1186/gb-2007-8-10-r214
Article
Google Scholar
Blondal T, Nielsen S, Baker A, Andreasen D, Mouritzen P, Teilum M, Dahlsveen I: Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2012, 59(2013):S1-S6.
Google Scholar
Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, Gamoudi A, Mourali N, Hechiche M, Rahal K, Levine PH: Inflammatory breast cancer in Tunisia, epidemiological and clinical trends. Cancer 2010, 116(11 suppl):2730-2735.
Article
Google Scholar
Chen W, Cai F, Zhang B, Barekati Z, Zhong XY: The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumor Biol 2012, 34(1):455-462.
Article
Google Scholar
Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, Qian W, O’Malley YQ, Askeland RW, Sugg SL, Qian J, Lin J, Jiang Z, Yee AJ, Sefton M, Deng Z, Shan SW, Wang CH, Yang BB: MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci 2013, 126(Pt 6):1440-1453.
Article
Google Scholar
Friedman E, Shang S, De Miera E, Fog J, Teilum M, Ma M, Berman R, Shapiro R, Pavlick A, Hernando E, Baker A, Shao Y, Osman I: Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med 2012, 10: 155. 10.1186/1479-5876-10-155
Article
Google Scholar
Giglio S, Cirombella R, Amodeo R, Portaro L, Lavra L, Vecchione A: MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27(Kip1) and p16(INK4a.). J Cell Physiol 2013, 228(10):2015-2023. 10.1002/jcp.24368
Article
Google Scholar
Heneghan HM, Miller N, Kerin MJ: Circulating miRNA signatures: promising prognostic tools for cancer. J Clin Oncol 2010, 28(29):e573-e574. 10.1200/JCO.2010.29.8901
Article
Google Scholar
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65: 7065-7070. 10.1158/0008-5472.CAN-05-1783
Article
Google Scholar
Laere SV, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, Van Dam P, Van Marck EA, Vermeulen PB, Dirix LY: Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Res Treat 2005, 93: 237-246. 10.1007/s10549-005-5157-z
Article
Google Scholar
Lehman HL, Van Laere SJ, Van Golen CM, Vermeulen PB, Dirix LY, Van Golen KL: Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Mol Cancer Res 2012, 10: 1306-1318. 10.1158/1541-7786.MCR-12-0173
Article
Google Scholar
Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P: miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet 2010, 6: 1000795. 10.1371/journal.pgen.1000795
Article
Google Scholar
Li X, Sanda T, Look AT, Novina CD, Von Boehmer H: Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med 2011, 208(4):663-675. 10.1084/jem.20102384
Article
Google Scholar
Li HY, Zhang Y, Cai JH, Bian HL: MicroRNA-451 inhibits growth of human colorectal carcinoma cells via down-regulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev 2013, 14(6):3631-3634. 10.7314/APJCP.2013.14.6.3631
Article
Google Scholar
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262
Article
Google Scholar
Lowery AJ, Miller N, McNeil RE, Kerin MJ: MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 2008, 14: 360-365. 10.1158/1078-0432.CCR-07-0992
Article
Google Scholar
Marrakchi R, Khadimallah I, Ouerhani S, Gamoudi A, Khomsi F, Bouzaine H, Benamor M, Bougatef K, Mnif S, Zitoun R, Benna F, Boussen H, Rahal K, Benammar Elgaaied A: Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients. Cancer Investigation 2009, 28(4):399-407.
Article
Google Scholar
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 2008, 105: 10513-10518. 10.1073/pnas.0804549105
Article
Google Scholar
Ng EKO, Li R, Shin VY, Jin HC, Leung CPH, Ma ESK, Pang R, Chua D, Chu KM, La WL, Law SYK, Poon RTP, Kwong A: Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One 2013, 8(1):e53141. 10.1371/journal.pone.0053141
Article
Google Scholar
Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H: Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010, 12: R90. 10.1186/bcr2766
Article
Google Scholar
Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451: 147-152. 10.1038/nature06487
Article
Google Scholar
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103: 2257-2261. 10.1073/pnas.0510565103
Article
Google Scholar
Wu F, Yang Z, Li G: Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 2009, 386(4):549. 10.1016/j.bbrc.2009.06.075
Article
Google Scholar